Alveolar Soft Part Sarcoma

subtype

Identifier: CI-CAN-00001776
Entity page: /cancer/alveolar-soft-part-sarcoma ↗
Edges: 79

Neighbours: 1 genes1 variants17 drugs10 trials
Drawn: 29 of 29 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Alveolar Soft Part Sarcoma approved for …APPROVED_FOR1 of 1
← approved for	Atezolizumabmonoclonal_antibody	supports	FDA ORIG	Alveolar Soft Part Sarcoma	1	Regulatory	openfda	graph →
Alveolar Soft Part Sarcoma diagnostic of …DIAGNOSTIC_OF1 of 1
diagnostic of

Alveolar Soft Part Sarcoma associated with …ASSOCIATED_WITH2 of 2
← associated with	TFE3 3 source records aggregated	supports	B	Alveolar Soft Part Sarcoma	3	Curated	civic	graph →
← associated with	TFE3	supports	D	Alveolar Soft Part Sarcoma	1	Curated	civic	graph →

Alveolar Soft Part Sarcoma associated with …ASSOCIATED_WITH2 of 2

← associated with

TFE3

3 source records aggregated

supports

Alveolar Soft Part Sarcoma investigated for …INVESTIGATED_FOR10 of 10
← investigated for	Ifosfamidesmall_molecule	unknown	3	Alveolar Soft Part Sarcoma	1	Curated	chembl	graph →
← investigated for	Doxorubicinsmall_molecule	unknown	3	Alveolar Soft Part Sarcoma	1	Curated	chembl	graph →
← investigated for	Dacarbazinesmall_molecule	unknown	3	Alveolar Soft Part Sarcoma	1	Curated	chembl	graph →
← investigated for	Sunitinibsmall_molecule	unknown	2	Alveolar Soft Part Sarcoma	1	Curated	chembl	graph →
← investigated for	Pembrolizumabmonoclonal_antibody	unknown	2	Alveolar Soft Part Sarcoma	1	Curated	chembl	graph →
← investigated for	Pazopanibsmall_molecule	unknown	2	Alveolar Soft Part Sarcoma	1	Curated	chembl	graph →
← investigated for	Cediranibsmall_molecule	unknown	2	Alveolar Soft Part Sarcoma	1	Curated	chembl	graph →
← investigated for	Bevacizumabmonoclonal_antibody	unknown	2	Alveolar Soft Part Sarcoma	1	Curated	chembl	graph →
← investigated for	Axitinibsmall_molecule	unknown	2	Alveolar Soft Part Sarcoma	1	Curated	chembl	graph →
← investigated for	Atezolizumabmonoclonal_antibody	unknown	2	Alveolar Soft Part Sarcoma	1	Curated	chembl	graph →

Alveolar Soft Part Sarcoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 29show all (up to 200)
→ investigated in trials for	Atezolizumabmonoclonal_antibody 3 trials (3 active) · roll-up of the cancer and its descendants	—	—	Alveolar Soft Part Sarcoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Cediranibsmall_molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Alveolar Soft Part Sarcoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Pazopanibsmall_molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Alveolar Soft Part Sarcoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Bevacizumabmonoclonal_antibody 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Alveolar Soft Part Sarcoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Doxorubicinsmall_molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Alveolar Soft Part Sarcoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Gemcitabinesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Alveolar Soft Part Sarcoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Ifosfamidesmall_molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Alveolar Soft Part Sarcoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Pembrolizumabmonoclonal_antibody 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Alveolar Soft Part Sarcoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Selinexorsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Alveolar Soft Part Sarcoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Axitinibsmall_molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Alveolar Soft Part Sarcoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Cabozantinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Alveolar Soft Part Sarcoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Carboplatinsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Alveolar Soft Part Sarcoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Cisplatinsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Alveolar Soft Part Sarcoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Cixutumumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Alveolar Soft Part Sarcoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Cyclophosphamidesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Alveolar Soft Part Sarcoma	1	Observed	clinicaltrials	graph →

Alveolar Soft Part Sarcoma studied in …STUDIED_INderived10 of 36show all (up to 200)
→ studied in	NCT05333458Phase 2 · recruiting Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, AXIOM Trial · condition mapped CURATED_BROADER · 36 trials mapped (15 active)	—	—	Alveolar Soft Part Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06066138Phase 1 · recruiting A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing · condition mapped CURATED_BROADER · 36 trials mapped (15 active)	—	—	Alveolar Soft Part Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07297667Phase 1 · recruiting GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours · condition mapped ONTOLOGY_EXACT · 36 trials mapped (15 active)	—	—	Alveolar Soft Part Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02867592Phase 2 · active not recruiting Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors · condition mapped ONTOLOGY_EXACT · 36 trials mapped (15 active)	—	—	Alveolar Soft Part Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04999761Phase 1 · recruiting AB122 Platform Study · condition mapped ONTOLOGY_EXACT · 36 trials mapped (15 active)	—	—	Alveolar Soft Part Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07104682early Phase 1 · active not recruiting A Study to Determine the Safety and Effectiveness of the Investigational Cellular Therapy GCAR1 in a Patient With Alveolar Soft Part Sarcoma · condition mapped ONTOLOGY_EXACT · 36 trials mapped (15 active)	—	—	Alveolar Soft Part Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03141684Phase 2 · active not recruiting Testing Atezolizumab Alone or Atezolizumab Plus Bevacizumab in People With Advanced Alveolar Soft Part Sarcoma · condition mapped CURATED_BROADER · 36 trials mapped (15 active)	—	—	Alveolar Soft Part Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06625190Phase 1/Phase 2 · recruiting Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors · condition mapped ONTOLOGY_EXACT · 36 trials mapped (15 active)	—	—	Alveolar Soft Part Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02180867Phase 2/Phase 3 · completed Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 36 trials mapped (15 active)	—	—	Alveolar Soft Part Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04332874Phase 2 · recruiting A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg · condition mapped ONTOLOGY_EXACT · 36 trials mapped (15 active)	—	—	Alveolar Soft Part Sarcoma	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains